Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Duchenne Muscular Dystrophy Market and Competitive Landscape 2014-2023: Pipeline, Epidemiology, Market Valuations, Product Sales, Market Forecast, Product Forecasts, and Market Shares - ResearchAndMarkets.com

Research and Markets
Posted on: 25 Oct 18

The "Global Duchenne Muscular Dystrophy Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

Global Duchenne Muscular Dystrophy Market and Competitive Landscape - 2018, provides comprehensive insights into Duchenne Muscular Dystrophy pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Duchenne Muscular Dystrophy market size and drug sales. This research also provides insights into Duchenne Muscular Dystrophy epidemiology and late stage pipeline.

Research Scope:

  • Duchenne Muscular Dystrophy pipeline: Find out the drugs in clinical trials for Duchenne Muscular Dystrophy by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Duchenne Muscular Dystrophy epidemiology: Find out the prevalence of Duchenne Muscular Dystrophy by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
  • Duchenne Muscular Dystrophy products: Identify key products marketed and prescribed for Duchenne Muscular Dystrophy by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Duchenne Muscular Dystrophy market size: Find out the market size for Duchenne Muscular Dystrophy drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
  • Duchenne Muscular Dystrophy drug sales: Find out the sales of Duchenne Muscular Dystrophy drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Duchenne Muscular Dystrophy drugs sales forecast: Sales forecast for Duchenne Muscular Dystrophy drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Duchenne Muscular Dystrophy market share analysis: Find out the market shares of Duchenne Muscular Dystrophy drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

For more information about this report visit https://www.researchandmarkets.com/research/br85n8/global_duchenne?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181025005815/en/

Business Wire
www.businesswire.com

Last updated on: 25/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.